| | Clonitrazolam Basic information |
| Product Name: | Clonitrazolam | | Synonyms: | Clonitrazolam;6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;8-Nitro-6-(2-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine;Clonazolam;8-Nitro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine;6-(2-chloro-phenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine;Clonazolam (CRM);Clonazolam solution | | CAS: | 33887-02-4 | | MF: | C17H12ClN5O2 | | MW: | 353.76 | | EINECS: | | | Product Categories: | pharmaceutical;research chemical;pharmaceutical intermediates;medical intermediate | | Mol File: | 33887-02-4.mol |  |
| | Clonitrazolam Chemical Properties |
| Boiling point | 576.0±60.0 °C(Predicted) | | density | 1.53±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | pka | 1.88±0.40(Predicted) | | form | A neat solid |
| | Clonitrazolam Usage And Synthesis |
| Description | Clonazolam is a benzodiazepine that was developed as a central nervous system depressant in the 1970s and has recently emerged as a drug of abuse. It potently antagonizes convulsions induced by thiosemicarbazide and pentobarbital (ED50s = 90 μg/kg for both agonists in mice). In vitro phase I metabolites of clonazolam, derived from human liver microsomes, have been described. This product is intended for forensic and research applications. | | Description | Clonazolam (CRM) (Item No. 25614) is a certified reference material categorized as a benzodiazepine. It is also categorized as a sedative and has been abused recreationally. This product is intended for research and forensic applications. | | Uses | 8-Nitro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine can be used as a central nervous system depressant. |
| | Clonitrazolam Preparation Products And Raw materials |
|